Table 3. Logistic regression analyses for clinical and sociodemographic correlates with normal and abnormal menstruation in the last 6 months in Canadian women living with HIV in CHIWOS cohort (n = 521).
Variable | Unadjusted | Adjusted | ||
---|---|---|---|---|
OR (95%CI) | P-value | OR (95%CI) | P-value | |
Age at Interview Date | 1.04 (1.01, 1.08) | 0.006 | 1.03 (1.00, 1.07) | 0.07 |
Duration of HIV Infection (months) | 1.004 (1.001, 1.007) | 0.003 | 1.002 (0.999, 1.005) | 0.147 |
Biological Mother/Sister who entered natural menopause before age 40 | <0.001 | 0.001 | ||
No | 1.00 (-) | 1.00 (-) | <0.001 | |
Yes | 7.46 (2.19, 25.37) | 5.01 (1.39, 18.03) | ||
Don’t Know | 3.05 (1.80, 5.16) | 2.53 (1.44, 4.45) | ||
Most Recent CD4 | 0.232 | Not Selected | ||
<350 | 1.00 (-) | |||
> = 350 | 0.65 (0.35, 1.21) | |||
Does not know | 0.56 (0.28, 1.09) | |||
Cigarette use | <0.001 | 0.017 | ||
Never | 1.00 (-) | 1.00 (-) | ||
Former | 0.96 (0.47, 1.93) | 0.61 (0.27, 1.40) | ||
Current | 2.30 (1.55, 3.41) | 1.69 (1.06, 2.68) | ||
Injection drug use | <0.001 | Not Selected | ||
Never | 1.00 (-) | |||
Previous use | 2.88 (1.70, 4.90) | |||
Current use | 4.53 (1.94, 10.57) | |||
Hepatitis B | 0.008 | 0.012 | ||
No | 1.00 (-) | 1.00 (-) | ||
Yes | 7.38 (1.69, 32.20) | 6.97 (1.52, 31.88) | ||
Hepatitis C | <0.001 | Not Selected | ||
No | 1.00 (-) | |||
Yes | 2.55 (1.62, 4.01) | |||
ART use | <0.001 | 0.030 | ||
Never on ARTs | 1.00 (-) | 1.00 (-) | ||
Previous ART | 3.90 (1.39, 10.95) | 2.11 (0.67, 6.43) | ||
Currently on ART | 4.20 (2.41, 7.33) | 2.36 (1.25, 4.45) | ||
Province Interview Conducted | <0.001 | 0.001 | ||
Ontario | 1.00 (-) | 1.00 (-) | ||
British Columbia | 4.83 (2.84, 8.21) | 2.95 (1.61, 5.39) | ||
Quebec | 2.26 (1.42, 3.60) | 1.9 (1.13, 3.09) | ||
Household gross yearly income | 0.040 | 0.061 | ||
$20 000 or more | 1.00 (-) | 1.00 (-) | ||
< $20 000 | 1.49 (1.02, 2.17) | 1.52 (0.98, 2.37) | ||
Education | 0.003 | Not Selected | ||
Less than high school | 1.00 (-) | |||
High school or greater | 0.38 (0.20, 0.71) | |||
Food Security | 0.151 | Not Selected | ||
Sufficient | 1.00 (-) | |||
Insufficient | 1.37 (0.89, 2.11) |
ART, antiretroviral therapy, VL, viral load